entity

Blood-brain barrier transport

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Blood-brain barrier transport: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

6Connections
3Hypotheses
2Analyses
1Outgoing
5Incoming
9Experiments
2Debates

No AI portrait yet

Outgoing (1)

TargetRelationTypeStr
Waste Clearanceinvolved_inprocess0.85

Incoming (5)

SourceRelationTypeStr
TXB2mediatescompound0.95
Tfr1mediatesreceptor0.95
Transferrin Receptor 1mediatesreceptor0.90
TFR1participates_ingene0.45
PDGFRBparticipates_ingene0.43

Targeting Hypotheses (3)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Magnetosonic-Triggered Transferrin Receptor Clustering 0.719 neurodegeneration Blood-brain barrier transport mechanisms
Pericyte Contractility Reset via Selective PDGFR-β Agonism 0.684 neurodegeneration Perivascular spaces and glymphatic clear
Transferrin-Alectinib Conjugation Enhances Blood-Brain Barri 0.406 molecular biology Does Alectinib truly bind C1q directly w

Mentioning Analyses (2)

Scientific analyses that reference this entity

Perivascular spaces and glymphatic clearance failure in AD

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.841

Blood-brain barrier transport mechanisms for antibody therapeutics

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.773

Experiments (9)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
iPSC-derived endothelial cell iron uptake with RLS CSF exposure exploratory restless legs syndrome 0.900 0.00 iPSC-derived human endothelial proposed N/A
Irisin effects on angiogenesis in human endothelial cells exploratory bone fracture 0.900 0.00 human umbilical vein endotheli proposed N/A
s:** - Compare brain penetration in FcRn+/+ vs FcRn-/- mice with engin falsification Neuroinflammation 0.400 0.50 mouse proposed $200,000
s:** - Compare uptake with/without magnetic particles using tight junc falsification Neurodegeneration 0.400 0.50 cell_line proposed $120,000
AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Therapy validation Parkinson's Disease 0.400 0.50 mouse proposed $280,000
AAV Serotype Comparison for LRRK2 Knockdown in PD validation Parkinson's Disease 0.400 0.50 mouse proposed $280,000
Proposed experiment from debate on Perivascular spaces and glymphatic falsification Neurodegeneration 0.400 0.50 cell_line proposed $100,000
Vascular Contribution to Alzheimer's Disease — Beyond Amyloid validation Alzheimer's Disease 0.400 0.50 human proposed $2,280,000
Vascular Contributions to Alzheimer Disease and Mixed Pathology clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Targeting ECM-producing cells with CAR-T therapy alleviates fibrosis in chronic [PMID:40848726] Zhao S, Li R, Xia Y, Wang X, Liu Z, Chu Cell Stem Cell 2025 1
Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease. [PMID:40425446] Sehlin D, Hultqvist G, Michno W, Aguilar J Prev Alzheimers Dis 2025 1
Neurovascular unit, neuroinflammation and neurodegeneration markers in brain dis [PMID:39526043] Kempuraj D, Dourvetakis KD, Cohen J, Val Front Cell Neurosci 2024 1
Effect of ferroptosis on chronic cerebral hypoperfusion in vascular dementia. [PMID:37709116] Fu P, Chen Y, Wu M, Bao B, Yin X, Chen Z Exp Neurol 2023 1
The Genetics of Primary Familial Brain Calcification: A Literature Review. [PMID:37446066] Chen SY, Ho CJ, Lu YT, Lin CH, Lan MY, T Int J Mol Sci 2023 1
Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmon [PMID:35257044] Calvier L, Herz J, Hansmann G JACC Basic Transl Sci 2022 1
On Iron Metabolism and Its Regulation. [PMID:33925597] Vogt AS, Arsiwala T, Mohsen M, Vogel M, Int J Mol Sci 2021 1
Decoding myofibroblast origins in human kidney fibrosis. [PMID:33176333] Kuppe C, Ibrahim MM, Kranz J, Zhang X, Z Nature 2021 1
Transferrin Receptor Is a Specific Ferroptosis Marker. [PMID:32160546] Feng H, Schorpp K, Jin J, Yozwiak CE, Ho Cell Rep 2020 1
APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. [PMID:32376954] Montagne A, Nation DA, Sagare AP, Barisa Nature 2020 1
Transferrin and transferrin receptors update. [PMID:29969719] Kawabata H Free Radic Biol Med 2019 1
Pathophysiology of Primary Familial Brain Calcification. [PMID:41212990] Keller A Annual review of physiology 2026 0
A FZD4/LRP5 agonist restores pericyte coverage and vascular integrity by increas [PMID:41890033] Levey J, Howe M, Douglas K, Odame E, Raj bioRxiv : the preprint server 2026 0
Time- and dose-dependent effects of bacterial infection on iron metabolism, infl [PMID:41619877] Lu Y, Zhang Y, Niu C Comp Biochem Physiol A Mol Int 2026 0
Ayanin combats against barium sulphate nanoparticles induced hepatotoxicity via [PMID:41666660] Zhu D, Lu Y, Jamil S, Ashfaq H, Al-Emam J Trace Elem Med Biol 2026 0
Role of iron and TfR1 in the application of high‑dose ascorbate against pancreat [PMID:41789665] Piotrowsky A, Leischner C, Schmieder H, Oncol Rep 2026 0
Nano-Enabled Fluorescence Switching: A Novel Strategy for PDGFRβ Detection and T [PMID:41884335] Fu X, Fan J, Chen H, Zheng Y, Liu Y, Zha Research (Washington, D.C.) 2026 0
Loss of Pericyte Exacerbates Alzheimer's Disease-Associated Retinal Pathology. [PMID:41814129] Hai-Chao C, Fu-Lin G, Jia-Xin C, Yi-Shu Clinical & experimental ophtha 2026 0
Yangxin granules exert cardioprotective effects against acute myocardial infarct [PMID:41868900] Huo G, Zhou Y, Wu Z, Sun S, Zhu G, Cheng American journal of translatio 2026 0
Conformational dynamics study of TfR1 upon transferrin binding via NMA and MD si [PMID:41921418] Zemmouche M, Falque G, Cadet F, Gardebie Journal of molecular graphics 2026 0

Debates (2)

Multi-agent debates referencing this entity

Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% brain penetrance. Engi

closed · Rounds: 4 · Score: 0.91 · 2026-04-06

Perivascular spaces and glymphatic clearance failure in AD

closed · Rounds: 4 · Score: 0.95 · 2026-04-06